Compartment specific expression of dendritic cell markers in human glomerulonephritis

Kidney International

Volumn 74, Issue 1, 2008, Pages 37-46

  Segerer, S ^a   Heller, F ^a   Lindenmeyer, M T ^a   Schmid, H ^a   Cohen, C D ^a   Draganovici, D ^a   Mandelbaum, J ^a   Nelson, P J ^a   Grone H J ^b   Grone E F ^b   Figel, A M ^c   Nossner E ^c   Schlondorff D ^a,d  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^c INSTITUTE OF EPIDEMIOLOGY   (Germany)

^d MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Dendritic cells; Glomerulonephritis; Interstitial inflammation; Macrophages

Indexed keywords

CD209 ANTIGEN; CD68 ANTIGEN; CELL MARKER; CREATININE; DENDRITIC CELL LYSOSOME ASSOCIATED MEMBRANE PROTEIN; LANGERIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MESSENGER RNA;

ARTICLE; BONE MARROW CELL; CONTROLLED STUDY; CORRELATION ANALYSIS; CREATININE BLOOD LEVEL; DENDRITIC CELL; GLOMERULONEPHRITIS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFLAMMATORY CELL; INTERSTITIAL NEPHRITIS; KIDNEY BIOPSY; LANGERHANS CELL; MACROPHAGE ACTIVATION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL;

EID: 45249111741     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2008.99     Document Type: Article

References (57)

1. Gordon S, Taylor PR. Monocyte and macrophage heterogeneity. Nat Rev Immunol 2005; 5: 953-964.
2. Hume DA. The mononuclear phagocyte system. Curr Opin Immunol 2006; 18: 49-53.
3. Naik SH, Sathe P, Park HY et al. Development of plasmacytoid and conventional dendritic cell subtypes from single precursor cells derived in vitro and in vivo. Nat Immunol 2007; 8: 1217-1226.
4. Shortman K, Naik SH. Steady-state and inflammatory dendritic-cell development. Nat Rev Immunol 2007; 7: 19-30.
5. Onai N, Obata-Onai A, Schmid MA et al. Identification of clonogenic common Flt3(+)M-CSFR(+) plasmacytoid and conventional dendritic cell progenitors in mouse bone marrow. Nat Immunol 2007; 8: 1207-1216.
6. Merad M, Ginhoux F. Dendritic cell genealogy: a new stem or just another branch? Nat Immunol 2007; 8: 1199-1201.
7. Quah BJ, O'Neill HC. Maturation of function in dendritic cells for tolerance and immunity. J Cell Mol Med 2005; 9: 643-654.
8. Steinman RM, Hemmi H. Dendritic cells: translating innate to adaptive immunity. Curr Top Microbiol Immunol 2006; 311: 17-58.
9. Banchereau J, Briere F, Caux C et al. Immunobiology of dendritic cells. Annu Rev Immunol 2000; 18: 767-811.
10. Gordon S. Alternative activation of macrophages. Nat Rev Immunol 2003; 3: 23-35.
11. Hart DN, Fabre JW. Demonstration and characterization of Ia-positive dendritic cells in the interstitial connective tissues of rat heart and other tissues, but not brain. J Exp Med 1981; 154: 347-361.
12. Kruger T, Benke D, Eitner F et al. Identification and functional characterization of dendritic cells in the healthy murine kidney and in experimental glomerulonephritis. J Am Soc Nephrol 2004; 15: 613-621.
13. Soos TJ, Sims TN, Barisoni L et al. CX3CR1+ interstitial dendritic cells form a contiguous network throughout the entire kidney. Kidney Int 2006; 70: 591-596.
14. Kerjaschki D, Regele HM, Moosberger I et al. Lymphatic neoangiogenesis in human kidney transplants is associated with immunologically active lymphocytic infiltrates. J Am Soc Nephrol 2004; 15: 603-612.
15. Woltman AM, de Fijter JW, Zuidwijk K et al. Quantification of dendritic cell subsets in human renal tissue under normal and pathological conditions. Kidney Int 2007; 71: 1001-1008.
16. Kaissling B, LeHir M. Characterization and distribution of interstitial cell types in the renal cortex of rats. Kidney Int 1994; 45: 709-720.
17. Austyn JM, Hankins DF, Larsen CP et al. Isolation and characterization of dendritic cells from mouse heart and kidney. J Immunol 1994; 152: 2401-2410.
18. Falini B, Flenghi L, Pileri S et al. PG-M1: a new monoclonal antibody directed against a fixative-resistant epitope on the macrophage-restricted form of the CD68 molecule. Am J Pathol 1993; 142: 1359-1372.
19. Segerer S, Cui Y, Hudkins KL et al. Expression of the chemokine monocyte chemoattractant protein-1 and its receptor chemokine receptor 2 in human crescentic glomerulonephritis. J Am Soc Nephrol 2000; 11: 2231-2242.
20. Segerer S, Henger A, Schmid H et al. Expression of the chemokine receptor CXCR1 in human glomerular diseases. Kidney Int 2006; 69: 1765-1773.
21. Segerer S, Hughes E, Hudkins KL et al. Expression of the fractalkine receptor (CX3CR1) in human kidney diseases. Kidney Int 2002; 62: 488-495.
22. Geijtenbeek TB, Torensma R, van Vliet SJ et al. Identification of DC-SIGN, a novel dendritic cell-specific ICAM-3 receptor that supports primary immune responses. Cell 2000; 100: 575-585.
23. Steinman RM. DC-SIGN: a guide to some mysteries of dendritic cells. Cell 2000; 100: 491-494.
24. Nakajima T, Kodama T, Tsumuraya M et al. S-100 protein-positive Langerhans cells in various human lung cancers, especially in peripheral adenocarcinomas. Virchows Arch A Pathol Anat Histopathol 1985; 407: 177-189.
25. Cocchia D, Tiberio G, Santarelli R et al. S-100 protein in 'follicular dendritic' cells or rat lymphoid organs. An immunochemical and immunocytochemical study. Cell Tissue Res 1983; 230: 95-103.
26. Xu W, Chen S, Huang J et al. The expression and distribution of S-100 protein and CD 83 in thyroid tissues of autoimmune thyroid diseases. Cell Mol Immunol 2004; 1: 378-382.
27. Perez L, Shurin MR, Collins B et al. Comparative analysis of CD1a, S-100, CD83, and CD11c human dendritic cells in normal, premalignant, and malignant tissues. Histol Histopathol 2005; 20: 1165-1172.
28. Asahina A, Tamaki K. Role of Langerhans cells in cutaneous protective immunity: is the reappraisal necessary? J Dermatol Sci 2006; 44: 1-9.
29. de Witte L, Nabatov A, Pion M et al. Langerin is a natural barrier to HIV-1 transmission by Langerhans cells. Nat Med 2007; 13: 367-371.
30. Dzionek A, Fuchs A, Schmidt P et al. BDCA-2, BDCA-3, and BDCA-4: three markers for distinct subsets of dendritic cells in human peripheral blood. J Immunol 2000; 165: 6037-6046.
31. Dzionek A, Sohma Y, Nagafune J et al. BDCA-2, a novel plasmacytoid dendritic cell-specific type II C-type lectin, mediates antigen capture and is a potent inhibitor of interferon alpha/beta induction. J Exp Med 2001; 194: 1823-1834.
32. Zimmer DB, Cornwall EH, Landar A et al. The S100 protein family: history, function, and expression. Brain Res Bull 1995; 37: 417-429.
33. Dzionek A, Inagaki Y, Okawa K et al. Plasmacytoid dendritic cells: from specific surface markers to specific cellular functions. Hum Immunol 2002; 63: 1133-1148.
34. Kluth DC, Erwig LP, Rees AJ. Multiple facets of macrophages in renal injury. Kidney Int 2004; 66: 542-557.
35. Sean Eardley K, Cockwell P. Macrophages and progressive tubulointerstitial disease. Kidney Int 2005; 68: 437-455.
36. John R, Nelson PJ. Dendritic cells in the kidney. J Am Soc Nephrol 2007; 18: 2628-2635.
37. Merad M, Collin M, Bromberg J. Dendritic cell homeostasis and trafficking in transplantation. Trends Immunol 2007; 28: 353-359.
38. Stout RD, Suttles J. Functional plasticity of macrophages: reversible adaptation to changing microenvironments. J Leukoc Biol 2004; 76: 509-513.
39. Wang Y, Wang YP, Zheng G et al. Ex vivo programmed macrophages ameliorate experimental chronic inflammatory renal disease. Kidney Int 2007; 72: 290-299.
40. Eardley KS, Zehnder D, Quinkler M et al. The relationship between albuminuria, MCP-1/CCL2, and interstitial macrophages in chronic kidney disease. Kidney Int 2006; 69: 1189-1197.
41. Yoshimoto K, Wada T, Furuichi K et al. CD68 and MCP-1/CCR2 expression of initial biopsies reflect the outcomes of membranous nephropathy. Nephron Clin Pract 2004; 98: c25-c34.
42. van Gisbergen KP, Geijtenbeek TB, van Kooyk Y. Close encounters of neutrophils and DCs. Trends Immunol 2005; 26: 626-631.
43. Gijzen K, Broers KM, Beeren IM et al. Binding of the adhesion and pathogen receptor DC-SIGN by monocytes is regulated by the density of Lewis X molecules. Mol Immunol 2007; 44: 2481-2486.
44. Segerer S, Banas B, Wornle M et al. CXCR3 is involved in tubulointerstitial injury in human glomerulonephritis. Am J Pathol 2004; 164: 635-649.
45. Masaki T, Chow F, Nikolic-Paterson DJ et al. Heterogeneity of antigen expression explains controversy over glomerular macrophage accumulation in mouse glomerulonephritis. Nephrol Dial Transplant 2003; 18: 178-181.
46. Morelli AE, Coates PT, Shufesky WJ et al. Growth factor-induced mobilization of dendritic cells in kidney and liver of rhesus macaques: implications for transplantation. Transplantation 2007; 83: 656-662.
47. Heller F, Lindenmeyer MT, Cohen CD et al. The contribution of B cells to renal interstitial inflammation. Am J Pathol 2007; 170: 457-468.
48. Segerer S, Mack M, Regele H et al. Expression of the C-C chemokine receptor 5 in human kidney diseases. Kidney Int 1999; 56: 52-64.
49. Stuht S, Gwinner W, Franz I et al. Lymphatic neoangiogenesis in human renal allografts: results from sequential protocol biopsies. Am J Transplant 2007; 7: 377-384.
50. Kerjaschki D, Huttary N, Raab I et al. Lymphatic endothelial progenitor cells contribute to de novo lymphangiogenesis in human renal transplants. Nat Med 2006; 12: 230-234.
51. Valladeau J, Duvert-Frances V, Pin JJ et al. The monoclonal antibody DCGM4 recognizes Langerin, a protein specific of Langerhans cells, and is rapidly internalized from the cell surface. Eur J Immunol 1999; 29: 2695-2704.
52. Stambach NS, Taylor ME. Characterization of carbohydrate recognition by Langerin, a C-type lectin of Langerhans cells. Glycobiology 2003; 13: 401-410.
53. McGreal EP, Martinez-Pomares L, Gordon S. Divergent roles for C-type lectins expressed by cells of the innate immune system. Mol Immunol 2004; 41: 1109-1121.
54. Treilleux I, Blay JY, Bendriss-Vermare N et al. Dendritic cell infiltration and prognosis of early stage breast cancer. Clin Cancer Res 2004; 10: 7466-7474.
55. Takahara K, Omatsu Y, Yashima Y et al. Identification and expression of mouse Langerin (CD207) in dendritic cells. Int Immunol 2002; 14: 433-444.
56. Segerer S, Bohmig GA, Exner M et al. Role of CXCR3 in cellular but not humoral renal allograft rejection. Transpl Int 2005; 18: 676-680.
57. Cohen CD, Frach K, Schlondorff D et al. Quantitative gene expression analysis in renal biopsies: a novel protocol for a high-throughput multicenter application. Kidney Int 2002; 61: 133-140.